Drugs / Cartistem(TM)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02755376 | Jan 2014 → Apr 2016 | — | Samsung Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cartistem (TM) | “Human cord blood derived mesenchymal stem cells and hyaluronic acid (Cartistem (TM)): 10” NCT02755376 ↗ |
| Modality | Cell therapy | “ACL reconstruction and concomitant Cartistem(TM) injection which is human cord blood derived mesenchymal stem cell under arthroscopy.” NCT02755376 ↗ |